Latest News
November 15, 2021
Not intended for U.S. and UK Media
Bayer extends clinical development program for finerenone with Phase III study in children and adolescents with chronic kidney disease
November 11, 2021
Not intended for U.S. and UK Media
New Phase III study to investigate expanded use of vericiguat in patients with chronic heart failure with reduced ejection fraction
November 09, 2021
Third quarter of 2021:
Bayer grows sales and earnings significantly

Find Your Product

With our products we contribute to the health of people and plants. Here you find an overview of the major Bayer products.